amidox has been researched along with Di Guglielmo Disease in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Elford, HL; Findenig, G; Fritzer-Szekeres, M; Novotny, L; Szekeres, T; Vachalkova, A | 1 |
1 other study(ies) available for amidox and Di Guglielmo Disease
Article | Year |
---|---|
Iron binding capacity of didox (3,4-dihydroxybenzohydroxamic acid) and amidox (3,4-dihydroxybenzamidoxime) new inhibitors of the enzyme ribonucleotide reductase.
Topics: Animals; Antineoplastic Agents; Enzyme Inhibitors; Humans; Hydroxamic Acids; Iron Compounds; Leukemia L1210; Leukemia, Erythroblastic, Acute; Mice; Oxidation-Reduction; Oximes; Polarography; Ribonucleotide Reductases; Tumor Cells, Cultured | 1997 |